Abstract
Neurofibromatosis(NF) is one of the hereditary neurocutaneous syndromes characterized by multiple tumors or hamartomas of central and peripheral nervous system and also concomitant skin and musculoskeletal system manifestations. There are two main types of NF, NF1 and NF2.
Tumors, hamartomas, and other developmental pathologies that interfere with the circulation or absorption of cerebrospinal fluid (CSF) may cause hydrocephalus in NF1. Large bilateral vestibular schwannomas and any other intracranial tumors related to NF2 may lead hydrocephalus by narrowing or obstructing the CSF passages. Treatment of hydrocephalus in NF depends on the underlying pathology that interferes with cerebrospinal fluid dynamics. Treatment strategies for hydrocephalus in NF include endoscopic third ventriculostomy, ventriculoperitoneal shunt implantation, and removal of the obstructive lesion.
References
Afifi AK, Jacoby CG, Bell WE, Menezes AH (1988) Aqueductal stenosis and neurofibromatosis: a rare association. J Child Neurol 3(2):125–130
Ardakani SKA, Aoude A, Ghodsi SM, Abdollahzadeh S, Khoshnevisan A (2014) Endoscopic third ventriculostomy in patients with vestibular schwannoma and hydrocephalus: a clinical trial. Neurosurg Q 24(4):267–271
Arkadir D, Fellig Y, Gomori MJ, Linetsky E, Shalom E, Lossos A (2012) Aggressive leptomeningeal gliomatosis in neurofibromatosis type 1. J Clin Oncol 30(27):e269–e270. https://doi.org/10.1200/JCO.2012.42.1719
Bailey P, Robitaille Y (1985) Primary diffuse leptomeningeal gliomatosis. Can J Neurol Sci 12(3):278–281
Balestrazzi P, de Gressi S, Donadio A, Lenzini S (1989) Periaqueductal gliosis causing hydrocephalus in a patient with neurofibromatosis type 1. Neurofibromatosis 2(5–6):322–325
Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, … Giovannini M (2012) Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A 158A(1):24–41. https://doi.org/10.1002/ajmg.a.34359
Castillo M, Kwock L, Green C, Schiro S, Wilson JD, Greenwood R (1995) Proton MR spectroscopy in a possible enhancing hamartoma in a patient with neurofibromatosis type 1. AJNR Am J Neuroradiol 16(4 Suppl):993–996
Chan JW (2012) Neuro-ophthalmic features of the neurocutaneous syndromes. Int Ophthalmol Clin 52(3):73–85, xi. https://doi.org/10.1097/IIO.0b013e318259df76
Chattopadhyay A, Kher AS, Thamke RM, Deshmukh CT, Bharucha BA (1994) Neurofibromatosis presenting with aqueductal stenosis. Indian J Pediatr 61(5):586–587
Corkill AG, Ross CF (1969) A case of neurofibromatosis complicated by medulloblastoma, neurogenic sarcoma, and radiation-induced carcinoma of thyroid. J Neurol Neurosurg Psychiatry 32(1):43–47
DeBella K, Poskitt K, Szudek J, Friedman JM (2000a) Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54(8):1646–1651
DeBella K, Szudek J, Friedman JM (2000b) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105(3 Pt 1):608–614
Dincer A, Yener U, Ozek MM (2011) Hydrocephalus in patients with neurofibromatosis type 1: MR imaging findings and the outcome of endoscopic third ventriculostomy. AJNR Am J Neuroradiol 32(4):643–646. https://doi.org/10.3174/ajnr.A2357
Dunn IF, Agarwalla PK, Papanastassiou AM, Butler WE, Smith ER (2007) Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I. Childs Nerv Syst 23(10):1191–1194. https://doi.org/10.1007/s00381-007-0343-4
Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26(1):93–97
Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, … Giovannini M (2009) Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res 15(16):5032–5039. https://doi.org/10.1158/1078-0432.CCR-08-3011
Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A(2):327–332. https://doi.org/10.1002/ajmg.a.33139
Foote KD, Friedman WA, Buatti JM, Meeks SL, Bova FJ, Kubilis PS (2001) Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 95(3):440–449. https://doi.org/10.3171/jns.2001.95.3.0440
Friedman JM (1993) Neurofibromatosis 1. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K (eds) GeneReviews(R). Seattle. Seattle (WA): University of Washington, Seattle; 1993-2018. ISSN: 2372-0697
Funasaki H, Winter RB, Lonstein JB, Denis F (1994) Pathophysiology of spinal deformities in neurofibromatosis. An analysis of seventy-one patients who had curves associated with dystrophic changes. J Bone Joint Surg Am 76(5):692–700
Gelabert Gonzales M, Bollar Zabala A, Prieto Gonzalez A et al (1990) Neurofibromatosis and stenosis of aqueduct of sylvius: a magnetic resonance assessment [Spanish]. Rev Med Univ Navarra 34:17–19
Gonen O, Wang ZJ, Viswanathan AK, Molloy PT, Zimmerman RA (1999) Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. AJNR Am J Neuroradiol 20(7):1333–1341
Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Mason G, Cheung S (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104(4):e49
Hayhurst C, Javadpour M, O’Brien DF, Mallucci CL (2006) The role of endoscopic third ventriculostomy in the management of hydrocephalus associated with cerebellopontine angle tumours. Acta Neurochir (Wien) 148(11):1147–1150; discussion 1150. https://doi.org/10.1007/s00701-006-0886-2
Ho SY, Kveton JF (2002) Rapid growth of acoustic neuromas after stereotactic radiotherapy in type 2 neurofibromatosis. Ear Nose Throat J 81(12):831–833
Horwich A, Riccardi VM, Francke U (1983) Brief clinical report: aqueductal stenosis leading to hydrocephalus – an unusual manifestation of neurofibromatosis. Am J Med Genet 14(3):577–581. https://doi.org/10.1002/ajmg.1320140322
Janet Elgallab JG (2015) Hydrocephalus in neurofibromatosis-three cases with different etiologies. Neurology 84(14):104
Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1–11. https://doi.org/10.1097/GIM.0b013e3181bf15e3
Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH (2013) Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol 39(1):46–52. https://doi.org/10.1016/j.ejso.2012.09.001
Kawano H, Hayashi M, Kabuto M, Kubota T, Yamamoto S (1985) Von Recklinghausen neurofibromatosis complicated with aqueductal stenosis. Report of two adult cases. Rinsho Shinkeigaku 25(3):336–341
King JA, Halliday W, Drake JM (2008) High-grade primary diffuse leptomeningeal gliomatosis in a child with neurofibromatosis type 1. J Neurosurg Pediatr 2(6):402–405. https://doi.org/10.3171/PED.2008.2.12.402
Krajevsca G, Perniola T (1979) Central von Recklinghausen disease: report of a clinical case with multifocal symptoms and hydrocephalus due to stenosis of the aqueduct (author’s transl) [In Italian]. Riv Patol Nerv Ment 99:308–316
Krauss JK, Nobbe F, Wakhloo AK, Mohadjer M, Vach W, Mundinger F (1992) Movement disorders in astrocytomas of the basal ganglia and the thalamus. J Neurol Neurosurg Psychiatry 55(12):1162–1167
Kulkarni AV, Drake JM, Kestle JR, Mallucci CL, Sgouros S, Constantini S, Canadian Pediatric Neurosurgery Study Group (2010) Endoscopic third ventriculostomy vs cerebrospinal fluid shunt in the treatment of hydrocephalus in children: a propensity score-adjusted analysis. Neurosurgery 67(3):588–593. https://doi.org/10.1227/01.NEU.0000373199.79462.21
Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 116(6):845–853
Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61(3):189–198. https://doi.org/10.1002/ana.21107
Little H, Kamat D, Sivaswamy L (2015) Common neurocutaneous syndromes. Pediatr Ann 44(11):496–504. https://doi.org/10.3928/00904481-20151112-11
Maria BL, Cafferty LL, Singer HS, Epstein JI, Carson BS (1986) Diffuse leptomeningeal seeding from a malignant spinal cord astrocytoma in a child with neurofibromatosis. J Neurooncol 4(2):159–163
Martinez-Lage JF (2010) Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst 26(11):1491; author reply 1493. https://doi.org/10.1007/s00381-010-1283-y
Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, … Pulst SM (1996) The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38(5):880–885; discussion 885–886
McCaughan JA, Holloway SM, Davidson R, Lam WW (2007) Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. J Med Genet 44(7):463–466. https://doi.org/10.1136/jmg.2006.048140
Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference (1988) Arch Neurol 45(5):575–578
Oka K, Kin Y, Go Y, Hirakawa K, Tomonaga M, Inoue T, Yoshioka S (1999) Neuroendoscopic approach to tectal tumors: a consecutive series. Neurosurg Focus 6(4):e14. https://doi.org/10.3171/foc.1999.6.4.15
Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52(4):450–461. https://doi.org/10.1002/ajmg.1320520411
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Viano J, Carceller-Benito F (2007) Aqueductal stenosis in the neurofibromatosis type 1. Presentation of 19 infantile patients. Rev Neurol 45(1):18–21
Pirouzmand F, Tator CH, Rutka J (2001) Management of hydrocephalus associated with vestibular schwannoma and other cerebellopontine angle tumors. Neurosurgery 48(6):1246–1253; discussion 1253–1254
Pou-Serradell A, Ugarte-Elola AC (1989) Hydrocephalus in neurofibromatosis. Contribution of magnetic resonance imaging to its diagnosis, control and treatment. Neurofibromatosis 2(4):218–226
Radhakrishnan K, Kak VK, Sridharan R, Chopra JS (1981) Adult aqueductal stenosis with Recklinghausen’s neurofibromatosis. Surg Neurol 16(4):262–265
Riccardi VM (1982) Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 7(2):1–34
Riviello JJ Jr, Marks HG, Lee MS, Mandell GA (1988) Aqueductal stenosis in neurofibromatosis. Neurofibromatosis 1(5–6):312–317
Roth J, Ber R, Wisoff JH, Hidalgo ET, Limbrick DD, Berger DS, … Constantini S (2017) Endoscopic third ventriculostomy in patients with neurofibromatosis type 1: a multicenter international experience. World Neurosurg 107:623–629. https://doi.org/10.1016/j.wneu.2017.08.053
Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, … Pavone L (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36(1):21–34. https://doi.org/10.1055/s-2005-837581
Ruggieri M, Pratico AD, Evans DG (2015) Diagnosis, management, and new therapeutic options in childhood neurofibromatosis type 2 and related forms. Semin Pediatr Neurol 22(4):240–258. https://doi.org/10.1016/j.spen.2015.10.008
Senveli E, Altinors N, Kars Z, Arda N, Turker A, Cinar N, Yalniz Z (1989) Association of von Recklinghausen’s neurofibromatosis and aqueduct stenosis. Neurosurgery 24(1):99–101
Shin HJ, Cho BK, Jung HW, Wang KC (1998) Pediatric pineal tumors: need for a direct surgical approach and complications of the occipital transtentorial approach. Childs Nerv Syst 14(4–5):174–178
Spadaro A, Ambrosio D, Moraci A, Albanese V (1986) Nontumoral aqueductal stenosis in children affected by von Recklinghausen’s disease. Surg Neurol 26(5):487–495
Sufianov AA, Sufianova GZ, Iakimov IA (2010) Endoscopic third ventriculostomy in patients younger than 2 years: outcome analysis of 41 hydrocephalus cases. J Neurosurg Pediatr 5(4):392–401. https://doi.org/10.3171/2009.11.PEDS09197
Sylvester CL, Drohan LA, Sergott RC (2006) Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol 17(1):7–11. https://doi.org/10.1097/01.icu.0000193070.32369.37
Tang TT, Whelan HT, Meyer GA, Strother DR, Blank EL, Camitta BM, Franciosi RA (1991) Optic chiasm glioma associated with inappropriate secretion of antidiuretic hormone, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites following ventriculoperitoneal shunting. Childs Nerv Syst 7(8):458–461
Tanrıkulu B, Singh G, Özek MM (2015) Surgical approach to mesencephalic tumors. In: Cinalli G, Özek MM, Maixner W, Sainte-Rose C (eds) Posterior fossa tumors in children, 1st edn. Springer International Publishing, Cham, pp 545–556
Ternier J, Wray A, Puget S, Bodaert N, Zerah M, Sainte-Rose C (2006) Tectal plate lesions in children. J Neurosurg 104(6 Suppl):369–376. https://doi.org/10.3171/ped.2006.104.6.369
Tripathy K, Mallik R, Mishra A, Misra D, Rout N, Nayak P, … Rath J (2010) A rare malignant triton tumor. Case Rep Neurol 2(2):69–73. https://doi.org/10.1159/000315621
Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, … et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75(4):826
Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61(4):762–766; discussion 766–767. https://doi.org/10.1227/01.NEU.0000298904.63635.2D
Umemura K, Hayashi N, Hamada H, Endo S, Takaku A (1998) Endoscopic third ventriculostomy in a case of obstructive hydrocephalus with neurofibromatosis (NF-1). No To Shinkei 50(5):427–431
Van Es S, North KN, McHugh K, De Silva M (1996) MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 26(7):478–487
Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P (2000) Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv Syst 16(7):417–420. https://doi.org/10.1007/PL00007285
Zamboni SL, Loenneker T, Boltshauser E, Martin E, Il’yasov KA (2007) Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 28(4):773–776
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Tanrıkulu, B., Özek, M.M. (2018). Neurofibromatosis and Hydrocephalus. In: Cinalli, G., Ozek, M., Sainte-Rose, C. (eds) Pediatric Hydrocephalus. Springer, Cham. https://doi.org/10.1007/978-3-319-31889-9_65-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31889-9_65-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31889-9
Online ISBN: 978-3-319-31889-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences